The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type IIIL-1 receptor to inhibit IL-1 action

被引:150
|
作者
Smith, DE
Hanna, R
Friend, D
Moore, H
Chen, H
Farese, AM
MacVittie, TJ
Virca, GD
Sims, JE
机构
[1] Amgen Corp, Seattle, WA 98101 USA
[2] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
D O I
10.1016/S1074-7613(02)00514-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulation of the activity of the proinflammatory cytokine IL-1 is complex, involving transcriptional and translational control, precursor processing, a receptor antagonist (IL-1ra), and a decoy receptor. Here we report that the soluble form of the IL-1 receptor accessory protein (AcP) increases the affinity of binding of human IL-1alpha and IL-1beta to the soluble human type 11 IL-1 receptor by approximately 100-fold, while leaving unaltered the low binding affinity of IL-1ra. Soluble AcP is present in normal human serum at an average concentration greater than 300 ng/ml. These findings suggest that the soluble form of IL-1 R AcP contributes to the antagonism of IL-1 action by the type 11 decoy receptor, adding another layer of complexity to the regulation of IL-1 action.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 50 条
  • [41] IL-1 INDUCES RAPID PHOSPHORYLATION OF THE IL-1 RECEPTOR
    GALLIS, B
    PRICKETT, KS
    JACKSON, J
    SLACK, J
    SCHOOLEY, K
    SIMS, JE
    DOWER, SK
    JOURNAL OF IMMUNOLOGY, 1989, 143 (10): : 3235 - 3240
  • [42] Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I
    Joosten, Leo A. B.
    van de Veerdonk, Frank L.
    Vonk, Alieke G.
    Boerman, Otto C.
    Keuter, Monique
    Fantuzzi, Giamilla
    Verschueren, Ineke
    van der Poll, Tom
    Dinarello, Charles A.
    Kullberg, Bart Jan
    Van der Meer, Jos W. M.
    Netea, Mihai G.
    APMIS, 2010, 118 (12) : 1000 - 1007
  • [43] IL-1 responsiveness may be regulated by interaction of interleukin-1 receptor accessory protein (IL-1 RACP) and interleukin-1 receptor type two (IL-4 RII).
    Lang, DL
    Wesche, H
    Knop, J
    Boraschi, D
    Martin, MU
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1149 - 1149
  • [44] Crystal structure of an IL-1 receptor antagonist peptide complexed with IL-1 receptor type I
    Brandhuber, BJ
    Dripps, DJ
    Edwards, CK
    Vigers, GPA
    FASEB JOURNAL, 2000, 14 (08): : A1394 - A1394
  • [45] A 7 amino acid motif in the IL-1 receptor accessory protein cytoplasmic tail is critical for IL-1 signaling
    Korherr, C
    Hofmeister, R
    Luger, K
    Gabler, S
    Falk, W
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 379 - 379
  • [46] Interleukin-1α (IL-1α), IL-1β, IL-1 receptor type I, IL-1 receptor antagonist, and TGF-β1 mRNAs in pediatric astrocytomas, ependymomas, and primitive neuroectodermal tumors
    Ilyin, SE
    Gonzalez-Gomez, I
    Gilles, FH
    Plata-Salaman, CR
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1998, 33 (02) : 125 - 137
  • [47] EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IS EXACERBATED BY IL-1-ALPHA AND SUPPRESSED BY SOLUBLE IL-1 RECEPTOR
    JACOBS, CA
    BAKER, PE
    ROUX, ER
    PICHA, KS
    TOIVOLA, B
    WAUGH, S
    KENNEDY, MK
    JOURNAL OF IMMUNOLOGY, 1991, 146 (09): : 2983 - 2989
  • [48] INHIBITION OF ACUTE MYELOGENOUS LEUKEMIA BLAST PROLIFERATION BY INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST AND SOLUBLE IL-1 RECEPTORS
    ESTROV, Z
    KURZROCK, R
    ESTEY, E
    WETZLER, M
    FERRAJOLI, A
    HARRIS, D
    BLAKE, M
    GUTTERMAN, JU
    TALPAZ, M
    BLOOD, 1992, 79 (08) : 1938 - 1945
  • [49] Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)
    Yilmaz-Elis, A. Seda
    Aartsma-Rus, Annemieke
    't Hoen, Peter A. C.
    Safdar, Huma
    Breukel, Cor
    van Vlijmen, Bart J. M.
    van Deutekom, Judith
    de Kimpe, Sjef
    van Ommen, Gert-Jan
    Verbeek, J. Sjef
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2013, 2 : e66
  • [50] Soluble type-I interleukin-1 receptor blocks chicken IL-1 activity
    Klasing, KC
    Peng, RK
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2001, 25 (04): : 345 - 352